|
|
Effect of abdominal aortic balloon occlusion combined with uterine remodeling for treating women with dangerous placenta previa and placental implantation |
The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, 450000 |
|
|
Abstract To explore the effects of different surgical methods for treating women with dangerous placenta previa and placental implantation, and to study its influence on the maternal and infant outcomes. Methods: The clinical data of 89 pregnant women with dangerous placenta previa and placenta accreta from March 2018 to May 2020 were collected retrospectively. According to the different surgical methods, these women were divided into two groups. 49 cases in the study group were treated with abdominal aortic balloon occlusion combined with uterine remodeling, and 40 cases in the control group were treated with abdominal aortic balloon occlusion. The differences of indicators, such as clinical efficacy, of the women were compared between the two groups. Results: The amount of intraoperative blood loss (1572.5±514.4ml), the operation time (91.3±13.6min), and the time of hospital stay (4.5±1.4d) of the women in the study group were significantly less than those (2253.9±611.2 ml, 108.5±16.4 min, and 6.8±1.6d) of the women in the control group. The improving degrees of the levels of creatine kinase, alpha-fetoprotein, and soluble vascular endothelial growth factor receptor-1 of the women in the study group were significantly better than those of the women in the control group (P<0.05). The incidence of postoperative complications (8.2%) of the women in the study group was significantly lower than that (30.0%) of the women in the control group (P<0.05). There was no significant difference in Apgar score of newborns (9.1±0.7 vs. 8.9±0.5) between the two groups (P>0.05). Conclusion: Abdominal aortic balloon occlusion combined with uterine remodeling for treating the pregnant women with dangerous placenta previa and placenta accreta has better effect, which can also reduce maternal complications without affecting the health of newborns.
|
|
|
|
|
|
|
|